Search

everythinglearnresearchcommunity

for

Search:↓

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Men with early baldness often have low vitamin D levels.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

Minoxidil helps prevent stress-caused hair loss in mice.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Apoptosis contributes to hair loss in androgenetic alopecia.

Hormones and genes affect hair growth and male baldness.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.